معرفی
Dr. Mohammed Alshawsh is a Senior Research Fellow in the Department of Paediatrics at Monash University. He holds adjunct roles as an Honorary Fellow with the Epi-Genomic Newborn Screening (EpiGNs) program and GenV initiative at Murdoch Children's Research Institute (MCRI), and as Adjunct Professor at University of Malaya's Pharmacology Department. Specializing in systematic reviews and meta-analysis methodologies, he supports evidence synthesis efforts in the Complex Autism and Neurodevelopmental Research Group (CAN). Over 14 PhD and 6 Master’s students have completed under his supervision, with ongoing guidance for 1 PhD and Honours candidates. His work spans neurodevelopmental disorders, newborn screening, and public health, contributing to UN Sustainable Development Goal 3 (Good Health and Well-being).
Education: Doctor of Philosophy (PhD) from University of Malaya (2013).
Research focuses on intellectual disability, autism spectrum disorders, and epidemiological studies. Notable projects include epigenomic newborn screening protocols and diagnostic yield analyses for developmental regression. His 100+ peer-reviewed publications (h-index 25) emphasize interdisciplinary approaches in pharmacology, toxicology, and molecular mechanisms.
Key collaborations involve institutions across Malaysia, Indonesia, and Australia. Active in methodological training, he has conducted 20+ workshops on rigorous evidence synthesis techniques.
